Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib

Author：                    

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.3, Iss.3, 2012-01, pp. : 713-717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report

By            

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2239-2243

Spandidos Publications

Access to resources Recommend Favorite

Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma

By                                  

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 187-191

Spandidos Publications

Access to resources Recommend Favorite

Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung

By Rahman Shakibur   Kondo Nobuyuki   Yoneda Kazue   Takuwa Teruhisa   Hashimoto Masaki   Orui Hayato   Okumura Yoshitomo   Tanaka Fumihiro   Kumamoto Kanako   Mostafa Mohammad   Chowdhury Golam   Haque Akramul   Hasegawa Seiki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 45-49

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics

By Motoshima Kohei   Nakamura Yoichi   Sano Kazumi   Ikegami Yoji   Ikeda Takaya   Mizoguchi Kosuke   Takemoto Shinnosuke   Fukuda Minoru   Nagashima Seiji   Iida Tetsuya   Tsukamoto Kazuhiro   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1299-1304

Springer Publishing Company

Access to resources Recommend Favorite

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

By Lu Rong-li   Hu Cheng-Ping   Yang Hua-ping   Li Yuan-yuan   Gu Qi-hua   Wu Lielin  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite